Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

NCT02917811 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT02917811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02917811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU
Lead sponsor
Università degli Studi di Ferrara
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
November 30, 2016
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biochemical marker, blood transfusion